One Organic Chemist One Day............Honouring Profiles of leading Organic Chemists brought to you by DR ANTHONY MELVIN CRASTO, worlddrugtracker, helping millions, amcrasto@gmail.com, +91 9323115463, India, skype amcrasto64
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Health
Outcomes Research, Prospective observational study Design and Analysis,
Health Economics, Trial-based and Model-based Economic Evaluation,
Clinical Trial Design, Studies involving Secondary Database Analyses,
Biostatistics, Late Phase Studies
Specialties:health economics
and outcomes research, study design and analyses, biostatistics,
patient-reported outcomes, health services research, market research,
product management
Shailja Dixit
Executive Director, Medical Affairs, Allergan
Earlier Head Global Evidence & Value Development-Diabetes & Aging Division at sanofi-aventis
Shailja is an accomplished healthcare executive and has 15+ years of
industry experience. She has served in variety of leadership role &
has a 360 degree understanding of healthcare industry having worked in
different industries within Healthcare. In her current role, she is
responsible for leading Global Health economic & outcomes team at
Actavis across entire portfolio. She has been instrumental in laying
foundation for new HEOR & Value model, collaborative research with
academia & stakeholder engagement strategies. Shailja has led
successful Global launches and has led the teams responsible for “end to
end “evidence development to support market access & reimbursement.
Summary
Accomplished
healthcare & pharmaceutical physician executive with more than 15
years of healthcare industry experience with Big Pharma (Sanofi and
Pfizer), Big-5 Consulting (Accenture), Payer(Aetna) and Provider Groups.
• Global perspective gained from roles in the US, Europe and Asia-Pacific in variety of areas:
• Big Pharma Experience in elderly population portfolio (Alzheimer’s,
pain, osteoarthritis, hearing disorder), metabolic (diabetes),
cardiovascular ( lipid lowering) and neutraceuticals.
• Experience in Device, Drug value and evidence development for a successful launch & optimum access in Global Markets
• Experience in Health Outcomes and Health Economics methodologies and models.
• Leading the Evidence and Value Development team in Therapeutic Strategic R&D Unit of Diabetes, PCSk9 and Aging.
• Responsible for end to end evidence creation starting with
identification of elements of differentiation, incorporating them into
R&D strategy working with cross function (R&D) teams and
finally, developing a successful payer value proposition i.e. Core Value
Dossier for optimal reimbursement & coverage.
•
Advised and lead projects for large payer organization laying
strategies for new payment and healthcare reforms like Accountable Care
Organizations and Medical Home.
• Help build strategies for evidence and value development for late stage projects/products
• Build launch readiness health outcomes and evidence generation plan for products in phase III
• Conducted strategy workshops for higher leadership in various pharma
companies to discuss impact of changing healthcare landscape.
• Worked across Phase II / III and IIIb / IV groups with input to
clinical development plans, publications and regional marketing
campaigns
• Clinical trial design, optimization of protocols, medical monitor and assistance with clinical trial operations
• Optimization of payer submissions / dossiers and regulatory responses
• Provided consultancy services to major payer on Value Based Reimbursement
Reporting
into GM & VP for Strategic Marketing, GE Healthcare,
responsibilities include leading product and strategies for Quality
Improvement, Clinical Decision Support and Business Intelligence.
• Led new product initiatives for Clinical Data Services focused on
Pharma Sector. Groomed, developed and managed the GE-Roche strategic
partnership for collaboration on type 2 diabetes “comprehensive
solution”. The comprehensive solution leverages the EMR based
interventions to increase adherence to standard of care, increase
compliance and study outcomes.
• Led meaningful use initiative for GE products working closely with provider community.
• Laid out strategy for Clinical Content, Decision Support Tools and
Business Intelligence (BI) offering for GE healthcare IT. The BI
offering provides advanced reporting and analytics tools for
pharmaceutical industry to support data needs for HEOR.
•
Led Clinical Decision support innovation team to create product
agnostics platform that will provide point of care decision support
based evidence based medicine.
• Developed and evangelized GE’s Total Population Management tools for
Chronic Disease Management product development in provider segments.
• Led customer collaboration efforts at Centricity-EMR (GE’s EMR) Health
User Group (CHUG ’08, ’09 and ‘10) to define role of Health Information
Technology to facilitate the changing role of physician in care
delivery i.e. collaboration and information sharing with patients and
family members.
• Filed 2 patents around Chronic Disease Management Decision support and Targeted Education (Evidence Based Medicine).
In
the Clinical Development/Analytics Team, responsibilities include being
clinical and informatics subject matter expert on International
projects. The international projects require a thorough knowledge of
Healthcare structure of the country, knowledge about Pfizer’s business
strategy in the target country. This also involved a thorough analysis
of HealthCare Information Technical and Electronic Tools used in the
country.
– (2 years)As
Head of Informatics (Clinical Consulting), leading a team of 4 analyst
and clinical consultants. The Clinical Consulting Team supports the
information needs of Aetna's Medical Directors, National Medical
Services, Health Care Delivery, Medical Cost Management, and other areas
of Aetna, to help improve member health, the efficiency of Aetna’s
operations, and the customer appeal of Aetna’s products and services
The
Government Medical College Aurangabad was founded in 1956 and it is one
of the premier medical institutions in the Maharashtra State.The
hospital of the college started with 300 beds in a small Nizam Bungalow
in 1960 is presently equipped with 1170 beds distributed across various
departments and wards . The foundation stone for the main building of
medical college was laid by then chief minister of Bombay State
Yashwantrao Chavan on 27 October 1957. The building was inaugurated by
Sushila Nayyar, then minister of Health, Government of India on 20 June
1964. Various other buildings were added to the campus over period of
time.
L-R Anando Sen Gupta, Rajendra Pratap Gupta , Dr. George Smoot (Nobel Laureate), Dr. Shailja Dixit
///////// MoUNTAIN VIEW CALIFORNIA VISITOR E MAIL ME amcrasto@gmail.com
.
